PUMA BIOTECHNOLOGY, INC.: cash_and_equivalents
| Value | {"amount": 36193000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2026-03-31) |
| Status | current |
| Entity | PUMA BIOTECHNOLOGY, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:37:37.097938+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/df7d737a-e7c8-4885-817a-3e215f4d1674
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-26-015633Retrieved: 2026-08-19T13:37:37.097938+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001401667/cash-and-equivalents/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/df7d737a-e7c8-4885-817a-3e215f4d1674
History
- no predecessors — first report